# A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

> **NCT03116113** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 50 (actual)

## Conditions studied

- X-Linked Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** BIIB112

## Key facts

- **NCT ID:** NCT03116113
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2020-11-18
- **Final completion:** 2020-11-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03116113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03116113, "A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03116113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*